LEE011 |
LEE-011A |
NVP-LEE011 |
RIBOCICLIB |
LEE-011 |
pubchem.compound:44631912 |
rxcui:1873916 |
chembl:CHEMBL3545110 |
drugbank:11730 |
chemidplus:1211441-98-3 |
Drug Class | Kinase Inhibitors |
FDA Approval | not approved |
Drug Class | Small molecule |
Drug Indications | antineoplastic agent |
FDA Approval | Breast cancer (HR+, HER2-) |
Drug Class | Small molecule inhibitor |
Drug Groups | investigational |
Drug Categories | antineoplastic agents |
Drug Categories | antineoplastic and immunomodulating agents |
Drug Categories | cytochrome p-450 cyp3a inhibitors |
Drug Categories | cytochrome p-450 cyp3a substrates |
Drug Categories | cytochrome p-450 cyp3a4 inhibitors |
Drug Categories | cytochrome p-450 cyp3a4 inhibitors (strong) |
Drug Categories | cytochrome p-450 cyp3a4 substrates |
Drug Categories | cytochrome p-450 cyp3a4 substrates (strength unknown) |
Drug Categories | cytochrome p-450 cyp3a4 substrates with a narrow therapeutic index |
Drug Categories | cytochrome p-450 enzyme inhibitors |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | heterocyclic compounds, fused-ring |
Drug Categories | highest risk qtc-prolonging agents |
Drug Categories | kinase inhibitor |
Drug Categories | protein kinase inhibitors |
Drug Categories | qtc prolonging agents |
inhibitor (inhibitory) |
antagonist (inhibitory) |
Mechanism of Interaction | Cyclin-dependent kinase 6 inhibitor |
Direct Interaction | yes |
Drug family | CDK4/6 inhibitor |
inhibitor (inhibitory) |
antagonist (inhibitory) |
Trial Name | LEE011 |
Novel drug target | Novel Target |
Specific Action of the Ligand | Inhibition |
n/a |
n/a |
n/a |
n/a |
RIBOCICLIB | DrugBank Drug Name |
1211441-98-3 | CAS Number |
Kisqali | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Groups | investigational |
KISQALI | Trade Name |
Drug Class | Small molecule inhibitor |
FDA Approval | Breast cancer (HR+, HER2-) |
LEE011 | Development Name |
Drug Class | Kinase Inhibitors |
Drug Indications | antineoplastic agent |
Drug Class | Small molecule |
FDA Approval | not approved |
D08MXP | TTD Drug ID |
RIBOCICLIB | GuideToPharmacology Ligand Name |